Influence of Polymorphism (-G308A) TNF-α on the Periportal Fibrosis Regression of Schistosomiasis after Specific Treatment

Genetic Testing and Molecular Biomarkers

Volumn 19, Issue 11, 2015, Pages 598-603

  Oliveira, Juliana B ^a   Silva, Paula C V ^a,b   Vasconcelos, Leticia M ^a   Gomes, Adriana V ^b   Coêlho, Maria Rosãngela C D ^a   Cahu, Georgea G O M ^a   Muniz, Maria Tereza Cartaxo ^b,c   Domingues, Ana Lúcia C ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c UNIVERSIDADE DE PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ARTICLE; BRAZILIAN; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; SCHISTOSOMIASIS; SPLENECTOMY; STOMACH VARICES; AGED; ANIMAL; BLOOD; COHORT ANALYSIS; FIBROSIS; GENETICS; ISOLATION AND PURIFICATION; LIVER DISEASES; MIDDLE AGED; PARASITOLOGY; PATHOLOGY; RISK FACTOR; SCHISTOSOMA MANSONI; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ANIMALS; COHORT STUDIES; FIBROSIS; GENOTYPE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; RISK FACTORS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84947726689     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2015.0091     Document Type: Article

References (35)

1. Abath FGC, Morais CNL, Montenegro CEL, et al. (2006) Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies? Trends Parasitol 22:85-91.
2. Abbas Z, Moatter T, Hussainy A, et al. (2005) Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3. World J Gastroenterol 11:6656-6661.
3. Andrade ZA (2005) Regression of hepatic fibrosis. Rev Soc Bras Med Trop 38:514-520.
4. Andrade ZA (2009) Schistosomiasis and liver fibrosis. Parasite Immunol 31:656-663.
5. Arnaud V, Li J, Wang Y, et al. (2008) Regulatory role of interleukin-10 and interferon in severe hepatic central and peripheral fibrosis in humans infected with Schistosoma japonicum. Infect Dis 198:418-426.
6. Bahr MJ, El Menuawy M, Boeker KH, et al. (2003) Cytokine gene polymorphisms and the susceptibility to liver cirrhosis in patients with chronic hepatitis C. Liver Int 23:420-425.
7. Bayley JP, Ottenhoff TH, Verweij CL (2004) Is there a future for TNF promoter polymorphisms? Genes Immun 5:315-329.
8. Booth M, Mwatha JK, Joseph S, et al. (2004) Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-γ, high TNF-α, or low RANTES, depending on age and gender. J Immunol 172:1295-1303.
9. Bouzgarrou N, Hassen E, Gabbouj S, et al. (2010) Lack of effect of tumor necrosis factor-alpha -308 G/A polymorphism on severity of liver fibrosis in Tunisian hepatitis C virus (HCV)-infected patients. Gastroenterol Clin Biol 34:297-304.
10. Cabrera M, Shaw MA, Sharpies C, et al. (1995) Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 182:1259-1264.
11. Dai CY, Chuang WL, Chang WY, et al. (2006) Tumor necrosis factor-α promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection. J Infect Dis 193:98-101.
12. De Jesus AR, Silva A, Santana LB, et al. (2002) Clinical and immunologic evaluation of 31 patients with acute schistosomiasis mansoni. Infect Dis 185:98-105.
13. Dessein A, Chevillard C, Arnaud V, et al. (2009) Variants of CTGF are associated with hepatic fibrosis in Chinese, Sudanese, and Brazilians infected with schistosomes. J Exp Med 12:1-8.
14. Feld JJ, Liang TJ (2006) Hepatitis C - identifying patients with progressive liver injury. Hepatology 43:S194-S206.
15. Goyal A, Kazim SN, Sakhuja P, et al. (2004) Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus. J Med Virol 72:60-65.
16. Guevara RR, Noya BA, Valero SK, et al. (2007) Clinical and ultrasound findings before and after praziquantel treatment among Venezuelan schistosomiasis patients. Rev Soc Bras Med Trop 40:505-511.
17. Henri S, Chevillard C, Mergani A, et al. (2002) Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-γ is associated with protection against fibrosis and TNF-α with aggravation of disease. J Immunol 169:929-936.
18. Ho SY, Wang YJ, Chen HL, et al. (2004) Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor alpha promoter gene. Cancer Causes Control 15:657-663.
19. Jeng JE, Tsai JF, Chuang LY, et al. (2007) Tumor necrosis factor-α 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia 9:987-992.
20. Jrad BBH, Chatti A, Laatiri A, et al. (2007) Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas. Eur J Haematol 78:117-122.
21. Kusumoto K, Uto H, Hayashi K, et al. (2006) Interleukin-10 or tumor necrosis factor-α polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine 34:24-31.
22. Magalhães A, Miranda DG, Miranda RG, et al. (2004) Cytokine profile associated with human chronic schistosomiasis mansoni. Mem Inst Oswaldo Cruz 99 Suppl I:21-26.
23. Moukoko CE, Wali NE, Saeed OK, et al. (2003) No evidence for a major effect of tumor necrosis factor alpha gene polymorphisms in periportal fibrosis caused by Schistosoma mansoni infection. Infect Immun 5456-5460.
24. Pordeus LC, Aguiar LR, Quinino LRM, et al. (2008) A ocorrência das formas aguda e crônica da esquistossomose mansônica no Brasil no período de 1997 a 2006: uma revisão de literatura. Epidemiol Serv Saúde 17:163-175.
25. Powell EE, Edwards SCJ, Hay JL, et al. (2000) Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 31:828-833.
26. Qin H, Liu B, Shi T, et al. (2010) Tumour necrosis factor-α polymorphisms and hepatocellular carcinoma: a meta-analysis. J Int Med Res 38:760-768.
27. Radwan MI, Pasha HF, Mohamed RH, et al. (2012) Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients. Cytokine 60:271-276.
28. Richardson M, Powell EE, Barrie HD, et al. (2005) A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C. J Med Genet 42, e45.
29. Richter J, Domingues ALC, Barata CH, et al. (2001) Report of the second satellite symposium on ultrasound in schistosomiasis. Mem Inst Oswaldo Cruz 96:151-156.
30. Rosen HR, McHutchison JG, Conrad AJ, et al. (2002) Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C. Am J Gastroenterol 97:714-720.
31. Schwabe RF, Brenner, DA (2006) Mechanisms of liver injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 290:583-589.
32. Silva PCV, Leal TV, Domingues ALC (2013) Treatment and education reduce the severity of schistosomiasis periportal fibrosis. Rev Soc Bras Med Trop 46:472-477.
33. Wilson AG, Symons JA, McDowell TL, et al. (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94:3195-3199.
34. World Health Organization (1993) Proposal for a practical guide to standardized use of ultrasound in the assessment of pathological changes. In: Meeting on Ultrasonography in Schistosomiasis, 1-4 October 1990, Cairo.
35. World Health Organization (2014) Programs and projects: schistosomiasis. A major publichealth Available at: www.who.int/schistosomiasis/en/, accessed December 15, 2014.